Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer

International Journal of Cancer

Volumn 79, Issue 3, 1998, Pages 278-282

  Bonnier, Pascal ^a,c   Bessenay, Frédéric ^a   Sasco, Annie J ^b   Beedassy, Bassodeo ^a   Lejeune, Christiane ^a   Romain, Sylvie ^a   Charpin, Colette ^a   Piana, Lucien ^a   Martin, Pierre Marie ^a  

^a Marseille Public Hospital System APHM   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL RECEPTOR; ESTROGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HORMONE RECEPTOR INTERACTION; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR SENSITIVITY;

ADULT; AGED; BODY WEIGHT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTORS, ESTRADIOL; RECEPTORS, PROGESTERONE; SURVIVAL ANALYSIS;

EID: 0031778512     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(199806)79:3<278::AID-IJC12>3.0.CO;2-5     Document Type: Article

References (23)

1. BERGKVIST, L., ADAMI, H.O., PERSSON, L, BEROSTRÖM, R. and KRUSEMO, U.B., Prognosis after breast-cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Amer. J. Epidemiol., 130, 221-228 (1989a).
2. BERGKVIST, L., ADAMI, H.O., PERSSON, I., HOOVER, R. and SCHAIRER, C., The risk of breast cancer after estrogen and estrogen-progestin replacement. New Eng. J. Med., 321, 293-297 (1989b).
3. BONNIER, P., ROMAIN, S., GIACALONE, P.L., LAFFARGUE, F., MARTIN, P.M. and PIANA, L., Clinical and biological prognostic factors in breast cancer diagnosed during post-menopausal hormone-replacement therapy. Obstet. Gynecol., 85, 11-17 (1995).
4. BRINTON, L.A., HOOVER, R.N. and FRAUMENI, J.F., Menopausal estrogens and breast-cancer risk: an expanded case-control study. Brit. J. Cancer, 54, 825-832 (1986).
5. COLDITZ, G.A., HANKINSON, S.E., HUNTER, D.J., WILLETT, W.C., MANSON, J.E., STAMPFER, M.J., HENNEKENS, C., ROSNER, B. and SPEIZER, F.E., The use of estrogens and progestins and the risk of breast cancer in post-menopausal women. New Engl. J. Med., 332, 1589-1593 (1995).
6. DUPONT, W. and PAGE, D.L., Menopausal estrogen-replacement therapy and breast cancer. Arch. intern. Med., 151, 67-72 (1991).
7. GAMBRELL, JR, R.D., Role of hormones in the etiology and prevention of endometrial and breast cancer. Acta obstet. gynecol. scand. Suppl., 106, 37-46 (1982).
8. GAMBRELL, JR, R.D., Proposal to decrease the risk and improve the prognosis in breast cancer. Amer. J. Obstet. Gynecol., 150, 119-128 (1984).
9. GAMBRELL, JR, R.D., Update on hormone-replacement therapy. Amer. Fam. Physician, 46, 87-96 (1992).
10. GREENBERG, E.R., VESSEY, M.P., MCPHERSON, K., DOLL, R. and YEATES, D., Body size and survival in pre-menopausal breast cancer. Brit. J. Cancer, 51, 691-697 (1985).
11. HAARBO, J., MARSLEW, U., GOTFREDSEN, A. and CHRISTIANSRN, C., Postmenopausal hormone-replacement therapy prevents central distribution of body fat after menopause. Metabolism, 40, 1323-1326 (1991).
12. HARDING, C., KNOX, W.F., FARAGHER, E.B., BAILDAM, A. and BUNDRED, N.J., Hormone-replacement therapy and tumour grade in breast cancer: prospective study in screening unit. Brit. med. J., 312, 1646-1647 (1996).
13. HENDERSON, B.E., The cancer question: an overview of recent epidemiologic and retrospective data. Amer. J. Obstet .Gynecol., 161, 1859-1864 (1989).
14. HENDERSON, B.E., PAGANINI-HILL, A. and ROSS, R.K., Decreased mortality in users of estrogen-replacement therapy. Arch. intern. Med., 151, 75-78 (1991).
15. HUNT, K., VESSEY, M. and MCPHERSON, K., Mortality in a cohort of long term users of hormone replacement therapy, an updated analysis. Brit. J. Obstet. Gynecol., 97, 1080-1086 (1990).
16. MAGNUSSON, C., HOLMBERG, L., NORDEN, T., LINDGREN, A. and PERSSON, T., Prognostic characteristics in breast cancer after hormone-replacement therapy. Breast Cancer Res. Treat., 38, 325-334 (1996).
17. MARTIN, P.M., ROLLAND, P., JACQUEMIER, J., ROLLAND, A.M. and TOGA, M., Multiple steroid receptors in human breast cancer. Relationships between steroid receptors and the activity of carcinomas throughout the pathological features. Cancer Chemother. Pharmacol., 2, 115-120 (1979).
18. ROMAIN, S., LAINE BIDRON, C., MARTIN, P.M. and MAGDELENAT, H. on behalf of the EORTC Receptor Study Group, Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. Europ. J. Cancer, 31A, 411-417 (1995).
19. SAEZ, S., MARTIN, P.M. and CHOUVET, C., Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels. Cancer Res., 30, 3468-3473 (1978).
20. SQUITIERI, R., TARTTER, P., AHMED, S., BROWER, S.T. and THEISE, N.D., Carcinoma of the breast in post-menopausal hormone-user and non-user control groups. J. Amer. Coll. Surg., 178, 167-170 (1994).
21. STEINBERG, K.K., THACKER, S.B., SMITH, S.J., STROUP, D.F., ZACK, M.M., FLANDERS, W.D. and BERKELMAN, R.L., A meta-analysis of the effect of estrogen-replacement therapy on the risk of breast cancer. J. Amer. med. Ass., 265, 1985-1990 (1991).
22. STRICKLAND, D.M., GAMBRELL, JR, R.D., BUTZIN, C.A. and STRICKLAND, K., The relationship between breast-cancer survival and prior post-menopausal estrogen use. Obstet. Gynecol., 80, 400-404 (1992).
23. YUEN, J., PERSSON, I., BERGKVIST, L., HOOVER, R., SCHAIRER, C. and ADAMI, H.O., Hormone-replacement therapy and breast-cancer mortality in Swedish women: results after adjustment for "healthy drug user" effect. Cancer Causes Control, 4, 369-374 (1993).